Singapore: National University of Singapore (NUS) and Life Sciences Group of Thermo Fisher Scientific have struck a stra...
Singapore: Merck and Pfizer have decided to co-promote Pfizer's anaplastic lymphoma kinase (ALK) inhibitor Xalkori (criz...
Singapore: The pharmaceutical manufacturing and sales subsidiary of Eisai, Sannova, has received approval for an additio...
Singapore: On 18 February, TAKE Solutions, a global business technology solutions provider, launched TAKE Academy of Lif...
Singapore: Medicago is collaborating with Mitsubishi Chemical to evaluate the latter's closed cultivation Plant Factory ...
Japanese pharma major Takeda Pharmaceutical Company Limited and ImmunoGen Inc., a biotechnology company that develops ta...
Singapore: Dainippon Sumitomo Pharma (DSP), a pharmaceutical company headquartered in Osaka, Japan, has established a wh...
Singapore: According to sources, the Tokyo-based pharma major Novartis, is likely to suffer temporary suspension by the ...
Each year big pharma giants end up spending billions of dollars in paying for fraud, misrepresentation of data and other...
Singapore: Furthering its aim to develop new drugs in segments with high unmet need, Japanese company Astellas entered i...
Singapore: Hong Kong Trade Development Council (HKTDC) and Modernized Chinese Medicine International Association (MCMIA ...
Singapore: Riken has launched a pilot study to assess the safety and feasibility of the transplantation of autologous in...
Hyderabad: With emphasis on cutting-edge innovations this year, BioAsia 2014 under the theme 'Innovate. Evolve.' kick-st...
Singapore: Japan is all set to host the 13th International Nanotechnology Exhibition and Conference, for three days from...
Singapore: Global phase III clinical trial of once-daily edoxaban for the treatment of acute symptomatic deep vein throm...
Singapore: UCB Japan received marketing approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) for Cim...
Singapore: Cardiologists at the University of Rochester Medical Center, US, are launching a new study in an effort to im...
Bangalore: Seoul-based Ildong has received a marketing and manufacturing approval for idiopathic pulmonary fibrosis (IPF...
